1-22913757-A-T

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PVS1_ModerateBS1_SupportingBS2

The NM_001309193.2(EPHB2):​c.3055A>T​(p.Lys1019*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00216 in 1,606,538 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).

Frequency

Genomes: 𝑓 0.011 ( 35 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 37 hom. )

Consequence

EPHB2
NM_001309193.2 stop_gained

Scores

1
6

Clinical Significance

risk factor no assertion criteria provided O:1

Conservation

PhyloP100: 0.261
Variant links:
Genes affected
EPHB2 (HGNC:3393): (EPH receptor B2) This gene encodes a member of the Eph receptor family of receptor tyrosine kinase transmembrane glycoproteins. These receptors are composed of an N-terminal glycosylated ligand-binding domain, a transmembrane region and an intracellular kinase domain. They bind ligands called ephrins and are involved in diverse cellular processes including motility, division, and differentiation. A distinguishing characteristic of Eph-ephrin signaling is that both receptors and ligands are competent to transduce a signaling cascade, resulting in bidirectional signaling. This protein belongs to a subgroup of the Eph receptors called EphB. Proteins of this subgroup are distinguished from other members of the family by sequence homology and preferential binding affinity for membrane-bound ephrin-B ligands. Allelic variants are associated with prostate and brain cancer susceptibility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0357 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0111 (1684/152300) while in subpopulation AFR AF= 0.0379 (1574/41560). AF 95% confidence interval is 0.0363. There are 35 homozygotes in gnomad4. There are 796 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 35 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPHB2NM_017449.5 linkc.*187A>T 3_prime_UTR_variant Exon 16 of 16 ENST00000374630.8 NP_059145.2 P29323-2Q6NVW1Q4LE53

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPHB2ENST00000400191.7 linkc.3055A>T p.Lys1019* stop_gained Exon 17 of 17 1 ENSP00000383053.3 P29323-1
EPHB2ENST00000374630.8 linkc.*187A>T 3_prime_UTR_variant Exon 16 of 16 1 NM_017449.5 ENSP00000363761.3 P29323-2
EPHB2ENST00000374632.7 linkc.*187A>T 3_prime_UTR_variant Exon 16 of 16 1 ENSP00000363763.3 P29323-3
EPHB2ENST00000374627.1 linkc.*1154A>T downstream_gene_variant 5 ENSP00000363758.1 B1AKC9

Frequencies

GnomAD3 genomes
AF:
0.0110
AC:
1675
AN:
152182
Hom.:
34
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0378
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00563
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00526
GnomAD3 exomes
AF:
0.00288
AC:
679
AN:
235858
Hom.:
15
AF XY:
0.00206
AC XY:
262
AN XY:
127432
show subpopulations
Gnomad AFR exome
AF:
0.0387
Gnomad AMR exome
AF:
0.00218
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000173
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.00254
GnomAD4 exome
AF:
0.00123
AC:
1794
AN:
1454238
Hom.:
37
Cov.:
31
AF XY:
0.00106
AC XY:
767
AN XY:
722618
show subpopulations
Gnomad4 AFR exome
AF:
0.0413
Gnomad4 AMR exome
AF:
0.00239
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000824
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000803
Gnomad4 OTH exome
AF:
0.00312
GnomAD4 genome
AF:
0.0111
AC:
1684
AN:
152300
Hom.:
35
Cov.:
32
AF XY:
0.0107
AC XY:
796
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.0379
Gnomad4 AMR
AF:
0.00562
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000176
Gnomad4 OTH
AF:
0.00521
Alfa
AF:
0.000628
Hom.:
2
Bravo
AF:
0.0127
ESP6500AA
AF:
0.0399
AC:
125
ESP6500EA
AF:
0.000279
AC:
2
ExAC
AF:
0.00335
AC:
406
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Significance: risk factor
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Prostate cancer/brain cancer susceptibility Other:1
Jun 01, 2006
OMIM
Significance: risk factor
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
3.6
DANN
Uncertain
0.98
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.61
FATHMM_MKL
Benign
0.41
N
Vest4
0.44
GERP RS
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs76826147; hg19: chr1-23240250; COSMIC: COSV65862296; COSMIC: COSV65862296; API